Brookline Capital Management Predicts CATX FY2024 Earnings
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Brookline Capital Management issued their FY2024 EPS estimates for Perspective Therapeutics in a report released on Monday, March 10th. Brookline Capital Management analyst K. Dolliver anticipates that the company will post earnings per share of ($0.88) for the year. Brookline Capital Management currently has a “Strong-Buy” rating […]
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Brookline Capital Management issued their FY2024 EPS estimates for Perspective Therapeutics in a report released on Monday, March 10th. Brookline Capital Management analyst K. Dolliver anticipates that the company will post earnings per share of ($0.88) for the year. Brookline Capital Management currently has a “Strong-Buy” rating […]
